
Sign up to save your podcasts
Or


Dave Dillon welcomes guest Jon Forster, former executive for Medical Risk Managers for a discussion about current Market conditions of the stop loss industry. We’ll cover current stop loss products in the market, the pipeline of cell and gene therapy, and new underwriting uses of AI. Jon has 20 years’ experience in actuarial leadership positions and recently moved to work full time with the Society of Actuaries to accelerate professional development offerings.
By Society of Actuaries (SOA)4.6
3131 ratings
Dave Dillon welcomes guest Jon Forster, former executive for Medical Risk Managers for a discussion about current Market conditions of the stop loss industry. We’ll cover current stop loss products in the market, the pipeline of cell and gene therapy, and new underwriting uses of AI. Jon has 20 years’ experience in actuarial leadership positions and recently moved to work full time with the Society of Actuaries to accelerate professional development offerings.

78,254 Listeners

32,090 Listeners

30,660 Listeners

25,883 Listeners

4,361 Listeners

1,384 Listeners

1,630 Listeners

112,467 Listeners

56,388 Listeners

9,519 Listeners

15 Listeners

11 Listeners

2 Listeners

2,107 Listeners

1,659 Listeners